Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
aggression
agitation
angiography, cerebral
autonomic dysfunction
bath salts, psychoactive
behavior, combative
behavioral disorder
behavioral disorder, acute
cannabinoids
cannabinoids, synthetic
CAT scan, abnormal
cerebrovascular accident
Clinical Pathologic Conference(C.P.C.)
cluster, geographic
complications
confusion
creatinine, elevated
delirium
delusion
designer drugs
drowsiness
drug abuse
drug abuse, toxic screen In
drug induced neurologic disorders
drug overdose
efficacy
encephalopathy
euphoria
hallucination
hallucinogens
intracerebral hemorrhage
lactic acidemia
marihuana
mental status, abnormal
methcathinone
mortality
nabilone
neurologic complications
neurotoxin
paranoia
Parkinson disease
Parkinson disease, nonmotor problems of
Parkinson disease, treatment of
psychosis
renal failure
renal failure, acute
rhabdomyolysis
safety
seizure
self harm
spice
stimulant drugs
stuporous
subarachnoid hemorrhage
sympathomimetic drugs
toxic encephalopathy
treatment of neurologic disorder
urine test in toxic screen
vasospasm
vasospasm, cerebral
violent behavior
zombie
Showing articles 1450 to 1500 of 6776 << Previous Next >>

Risk of Intracerebral Hemorrhage in Patient with Cerebral Microbleeds Undergoing Endovascular Intervention
Stroke 43:1532-1536, Soo, Y.O.Y.,et al, 2012

Adverse Effect of Early Epileptic Seizures in Patients Receiving Endovascular Therapy for Acute Stroke
Stroke 43:1584-1590, Jung, S.,et al, 2012

Immunotherapy-Responsive Chorea as the Presenting Feature of LGI1-Antibody Encephalitis
Neurol 79:195-196, Tofaris,G.K.,et al, 2012

Primary Sjogren Syndrome
BMJ 344:e3821, Ramos-Casals, M.,et al, 2012

The Benefits and Harms of Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator within 6 h of Acute Ischaemic Stroke (the third international stroke trial IST-3): a Randomised Controlled Trial
Lancet 379: 2320, IST-3 collaborative group, 2012

Recombinant Tissue Plasminogen Activator for Acute Ischaemic Stroke: An Updated Systematic Review and Meta-Analysis
Lancet 379: 2364-2372, Wardlaw, J.M.,et al, 2012

Preexposure Prophylaxis for HIV - Where Do We Go from Here?
NEJM 367:459-461,462, Cohen, M.S. & Baden, L.R., 2012

Radiation Exposure from CT Scans in Childhood and Subsequent Risk of Leukemia and Brain Tumors: A Retrospective Cohort Study
Lancet 380:499-505, Pearce, M.S.,et al, 2012

An Unexpected Trismus
Lancet 380:536, Alves, M.,et al, 2012

Evidence-Based Guideline: Pharmacologic Treatment of Chorea in Huntington Disease
Neurol 79:597-603, Armstrong, M.J. & Miyasaki, J.M., 2012

Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
NEJM 367:625-635, Olesen, J.B.,et al, 2012

Multimodal Imaging of Reversible Cerebral Vasoconstriction Syndrome: A Series of 6 Cases
AJNR 33:1403-1410, Marder, C.P.,et al, 2012

Antiplatelets vs Anticoagulation for Dissection
Neurol 79:686-689, Kennedy, F.,et al, 2012

Pregnancy-related Hemangioblastoma Progression and Complications in Von Hippel-Lindau Disease
Neurol 72:793-796, Frantzen, C.,et al, 2012

Hyperosmolar Therapy for Raised Intracranial Pressure
NEJM 367:746-752, Ropper, A.H., 2012

Adult Primary Central Nervous System Vasculitis
Lancet 380:767-777, Salvarani, C.,et al, 2012

Early Administration of Aspirin in Patients Treated with Alteplase for Acute Ischaemic Stroke: A Randomised Controlled Trial
Lancet 380:731-737, Zinkstok, S.M.,et al, 2012

Elderly Patients are at Higher Risk for Poor Outcomes after Intra-Arterial Therapy
Stroke 43:2356-2361, Chandra, R.V.,et al, 2012

Hemostatic Therapy Should be Used for Acute Treatment of Anticoagulation-Related Intracerebral Hemorrhage
Stroke 43:2535-2536,2539, Diringer, M. & Zazulia, A.R., 2012

Hemostatic Therapy Should not be Used for Acute Treatment of Anticoagulation-Related Intracerebral Hemorrhage
Stroke 43:2537-2538,2539, Stapf, C., 2012

Clinicopathologic Conference, Paraneoplastic Stiff Person Syndrome with Limbic Encephalitis with Anti-Amphiphysin Antibodies with Metastatic Carcinoma of Breast
NEJM 367:851-861, Case 27-2012, 2012

Effects of Clopidogrel Added to Aspirin in Patients with Recent Lacunar Stroke
NEJM 367:817-825, The SPS3 Investigators, 2012

Morvan Syndrome: Clinical and Serological Observations in 29 Cases
Ann Neurol 72:241-255, Irani, S.R.,et al, 2012

Solitaire Flow Restoration Device Versus the Merci Retriever in Patients with Acute Ischaemic Stroke (SWIFT): a Randomised, Parallel-Group, Non-Inferiority Trial
Lancet 380:1241-1249,1208, Saver, J.L.,et al, 2012

Trevo Versus Merci Retrievers for Thrombectomy Revascularisation of Large Vessel Occlusions in Acute Ischaemic Stroke (TREVO 2): A Randomised Trial
Lancet 380:1231-1240,1208, Nogueira, R.G.,et al, 2012

Neurologic Manifestations of E Coli infection - induced Hemolytic-Uremic Syndrome in Adults
Neurol 79:1466-1473, Weissenborn, K.,et al, 2012

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
NEJM 367:1098-1106,1149, Gold, R.,et al, 2012

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
NEJM 367:1087-1097,1149, Fox, R.J.,et al, 2012

Extreme Delta Brush
Neurol 79:1094-1100, Schmitt, S.E.,et al, 2012

Risk Factors for Intracranial Hemorrhage in Acute Ischemic Stroke Patients Treated with Recombinant Tissue Plasminogen Activator
Stroke 43:2904-2909, Whiteley, W.N.,et al, 2012

Selective Serotonin Reuptake Inhibitors May be Helpful in Most Patients with Stroke
Stroke 43:3150-3151,3154, Chollet, F., 2012

Should Every Patient with Stroke be on Selective Serotonin Reuptake Inhibitors?
Stroke 43:3152-3153,3154, Marshall, R.S., 2012

Serious Cardiac Arrhythmias after Stroke Incidence, Time Course, and Predictors - A Systematic, Prospective Analysis
Stroke 43:2892-2897, Kallmunzer, B.,et al, 2012

Neurologic Outcomes and Adjunctive Steroids in HIV Patients with Severe Cerebral Toxoplasmosis
Neurol 79:1762-1766, Sonneville, R.,et al, 2012

Multiple Cerebral Air Emboli During Upper Gastrointestinal Endoscopy
JNNP 83:1110-1111, Koster, G.T.,et al, 2012

Dropped Head Syndrome: Report of Three Cases During Treatment with a Mek Inhibitor
Neurol 79:1929-1932, Chen, X.,et al, 2012

Generalised Periodic Discharges in the Critically Ill
Neurol 79:1951-1960,1940, Foreman, B.,et al, 2012

Tumefactive Multiple Sclerosis Lesions under Fingolimod Treatment
Neurol 79:2000-2002,1942, Visser, F.,et al, 2012

Severe Relapses under Fingolimod Treatment Prescribed after Natalizumab
Neurol 79:2004-2006,1942, Centonze, D.,et al, 2012

Multiple Sclerosis Rebound Following Herpes Zoster Infection and Suspension of Fingolimod
Neurol 79:2006-2007,1942, Gross, C.M.,et al, 2012

Varicella-Zoster Virus Encephalitis and Vasculopathy in a Patient Treated with Fingolimod
Neurol 79:2002-2004,1942, Ratchford, J.,et al, 2012

Central Nervous System Aspergillosis
Medicine 91:328-336, Kourkoumpetis, T.,et al, 2012

Fungal Infections Associated with Contaminated Methylprednisolone in Tennessee
NEJM 367:2194-2203, Kainer, M.,et al, 2012

Advances in Treatment of Bacterial Meningitis
Lancet 380:1693-1702,1623, Van de Beek, D.,et al, 2012

An Uncommon Cause of Intracerebral Hemorrhage in a Healthy Truck Driver
Arch Neurol 69:1500-1503, Gokhale, S.,et al, 2012

PML-IRIS in a patient treated with Brentuximab
Neurol 79:2075-2077, Geldern, G.,et al, 2012

Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomized controlled trial
Lancet 380:1749-1758, Lopes, R.,et al, 2012

Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised
Neurol 79:2125-2132, Tan, L.,et al, 2012

Subdural empyema in bacterial meningitis
Neurol 79:2133-2139, Jim, K.,et al, 2012

Alemtuzumab for Multiples Sclerosis: Who and When to treat?
Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012



Showing articles 1450 to 1500 of 6776 << Previous Next >>